$58.8M in expenses

Versiti indiana recruits volunteer blood donors and collects, processes, and distributes blood products as part of its mission to provide a safe and reliable blood supply for hospitals and healthcare systems across indiana and ohio. In 2024, versiti indiana collected total red blood cells and platelets of 141,860, serving 65 hospitals through 3,978 community blood drives that engaged 55,702 volunteer donors. Innovation: versiti indiana partnered with the crawfordsville fire department and henry county EMS to provide prehospital whole blood transfusions for critically injured trauma patients, improving (continued in schedule o) survival rates by enabling rapid field transfusions. Versiti indiana also participated in the we give blood drive with abbott and the big ten conference. Community outreach: versiti indiana engaged communities through lifeline @ butler, sigma gamma rho sorority partnership, indiana black expo support, circle city classic radio initiatives, and the #knowscd sickle cell disease awareness campaign. Diagnostic testing: versiti indiana provides diagnostic testing services including hematology, coagulation, and molecular diagnostics, conducting 35,345 tests in 2024. Msi: the medical services institute performed 8 therapeutic procedures and operates clinical research programs to advance patient care. Through dedicated volunteer donors and strategic partnerships, versiti indiana maintains a robust blood supply enabling hospitals to provide critical care and lifesaving treatments throughout the region.

$21.8M in expenses

The versiti donor testing laboratory (DTL) provides infectious disease testing to determine donor suitability and product safety for organs, tissues, hematopoietic STEM cells, and cord blood. The DTL offers nucleic acid testing, antibody screening, and confirmatory testing for many different disease states. In 2024, the DTL conducted 8,321,196 donor tests, ensuring the safety of its donated biological products. As part of versiti's mission to maintain the safest possible blood supply, donor testing operations conduct mandatory screening for transfusion-transmissible infections as required by FDA regulations. The DTL utilizes state-of-the-art nucleic acid testing (nat) technology and serological methods to detect infectious agents. Versiti's DTL supports blood collection activities (continued in schedule o) across versiti's entire geographic footprint while maintaining rigorous quality standards and regulatory compliance. Versiti's donor testing services strengthen the national blood supply infrastructure. By ensuring comprehensive donor screening, versiti protects patients who depend on safe blood transfusions, strengthens the national blood supply, and supports the broader public health mission of maintaining confidence in a high-quality blood supply.